Welcome to your daily briefing on healthcare developments in Indiana. Today we're covering 5 key stories including updates on indiana healthcare headlines, indiana healthcare updates, background & context. Let's dive in.
2 stories
The Indiana Health Information Exchange improves health and healthcare through information exchange, powered by data developed by the Regenstrief Institute's Indiana Network.
For Indiana healthcare professionals, IHIE offers a statewide infrastructure to streamline patient data access and care coordination across the state.
A comprehensive guide explains hospital licenses and certificate registration requirements, including a detailed list of essential hospital compliance documentation.
IN healthcare administrators can apply these regulatory frameworks to benchmark their own facility licensing protocols and ensure operational readiness.
Reach healthcare professionals
0 stories
3 stories
The MIPS cost performance category is calculated retrospectively by CMS using attributed Medicare claims; clinicians cannot directly affect what is attributed. The two attribution methods (TPCC and MSPB) capture different beneficiary cohorts. Practices that try to "manage" cost without understanding which patients are attributed to which clinician typically waste effort.
Cost is now 30% of the MIPS final score — the largest single category. Misunderstanding attribution is the leading cause of unfavorable payment adjustments in the next cycle.
A vendor is a business associate if they create, receive, maintain, or transmit PHI on behalf of the covered entity. They are NOT a business associate just because they happen to be in a building with PHI or could conceivably access it. The functional test matters, not the proximity test.
Forcing BAA execution on vendors who do not meet the functional test creates contractual bloat and weakens the negotiating position with vendors who actually do. Failing to execute BAAs with true business associates exposes the covered entity to OCR enforcement.
Covered entities must annually recertify their 340B eligibility through HRSA. Missing the recertification window pushes the entity to inactive status, which means immediate loss of 340B pricing and potentially diversion violations on previously dispensed drugs. Reinstatement requires a new application.
The discount value of 340B pricing for a covered entity often exceeds six figures annually. Letting the recertification lapse for paperwork reasons is one of the most expensive administrative errors in the regulation.
Get Indiana healthcare intelligence delivered to your inbox every morning.
Subscribe FreeView all past issues
Feature your brand across the U.S., Canada, and select international markets and 10 industry verticals.
Become a National Partner